Fulcrum Asset Management’s Idexx Laboratories IDXX Stock Holding History

Fulcrum Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$565K	Buy	1,055 +18	+2%	+$10.1K	0.06%	267
2026 Q1	$578K	Hold	1,037	–	–	0.09%	126
2025 Q4	$708K	Buy	1,037 +152	+17%	+$104K	0.2%	83
2025 Q3	$565K	Hold	885	–	–	0.16%	89
2025 Q2	$475K	Buy	+885	New	+$423K	0.14%	104
2022 Q1	–	Hold	0	–	–	–	11
2021 Q4	–	Hold	0	–	–	–	78
2021 Q3	–	Hold	0	–	–	–	79
2021 Q1	–	Hold	0	–	–	–	92
2020 Q4	–	Hold	0	–	–	–	3
2020 Q3	–	Sell	-24,161	Closed	-$8.93M	–	2
2020 Q2	$8.43M	Buy	+24,161	New	+$7M	2.83%	3

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fulcrum Asset Management's IDXX Position: Q2 2026 in Review

Fulcrum Asset Management increased its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, buying an estimated $10.1K and bringing the position to 1,055 shares worth $565K. The position accounts for 0.06% of the portfolio, ranked #267.

Fulcrum Asset Management first reported a position in IDXX in Q2 2020 and has held it in 6 quarters since. The position peaked at $8.43M in Q2 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Fulcrum Asset Management held 1,055 shares of Idexx Laboratories worth $565K as of Q2 2026.
Fulcrum Asset Management bought 18 Idexx Laboratories shares in Q2 2026, an estimated $10.1K.
Idexx Laboratories made up 0.06% of Fulcrum Asset Management's portfolio in Q2 2026, its #267 holding.
Fulcrum Asset Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 6 quarters since.
Fulcrum Asset Management's Idexx Laboratories position peaked at $8.43M in Q2 2020.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.